Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparisonBen M. Eyck, Berend J. van der Wilk, Yhi Wong et al.|British journal of surgery|2022Cited by 15
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: prospective multicentre preSINO trialYang Yang, Zhigang Li, Zhichao Liu et al.|British journal of surgery|2025Cited by 11
Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysisXiaoli Zheng, Hong Ge, Yanan Sun et al.|Thoracic Cancer|2021Cited by 5
Outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal squamous cell carcinoma in East Asia versus Western EuropeBen M. Eyck, Jan van Lanschot, Xing Gao et al.|European Journal of Surgical Oncology|2022Cited by 0
508. OUTCOME OF NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN EAST ASIA VERSUS WESTERN EUROPEBen M. Eyck, Jan van Lanschot, Xing Gao et al.|Diseases of the Esophagus|2022Cited by 0